Keywords
Last Name
Institution

Thomas Wells

TitleProfessor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentORRA, College of Research Administration
Address105I Biomedical Research I
325 S. Elm St.
Mail Slot # 718-3
Little Rock AR 72205
Phone501-603-1638
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Emslie GJ, Wells TG, Prakash A, Zhang Q, Pangallo BA, Bangs ME, March JS. Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorder. J Child Adolesc Psychopharmacol. 2015 May; 25(4):293-305. PMID: 25978741.
      View in: PubMed
    2. Webb NJ, Wells TG, Shahinfar S, Massaad R, Dankner WM, Lam C, Santoro EP, McCrary Sisk C, Blaustein RO. A randomized, open-label, dose-response study of losartan in hypertensive children. Clin J Am Soc Nephrol. 2014 Aug 07; 9(8):1441-8. PMID: 24875194; PMCID: PMC4123403.
    3. Bian J, Xie M, Hogan W, Hutchins L, Topaloglu U, Lane C, Holland J, Wells T. CLARA: an integrated clinical research administration system. J Am Med Inform Assoc. 2014 Oct; 21(e2):e369-73. PMID: 24778201; PMCID: PMC4173184.
    4. Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, McCrary Sisk C, Lam C. Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome. Pediatr Nephrol. 2013 May; 28(5):737-43. PMID: 23207876.
      View in: PubMed
    5. Wells TG, Blowey DL, Sullivan JE, Blumer J, Sherbotie JR, Song S, Rohatagi S, Heyrman R, Salazar DE. Pharmacokinetics of olmesartan medoxomil in pediatric patients with hypertension. Paediatr Drugs. 2012 Dec 01; 14(6):401-9. PMID: 22880942.
      View in: PubMed
    6. Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP, Sisk CM, Lam C. Losartan and enalapril are comparable in reducing proteinuria in children. Kidney Int. 2012 Oct; 82(7):819-26. PMID: 22739977.
      View in: PubMed
    7. Redwine K, Howard L, Simpson P, Li SH, Yan K, James L, Blumer J, Sullivan J, Ward R, Wells T. Effect of placebo on ambulatory blood pressure monitoring in children. Pediatr Nephrol. 2012 Oct; 27(10):1937-42. PMID: 22623022; PMCID: PMC3423579.
    8. Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim G, Santoro EP, Sisk CM, Lam C. Long-Term Maintenance of Efficacy with Losartan in Children with Alport Syndrome: Results from a Subgroup Analysis of a Randomized Controlled Trial. 2012.
    9. Wells T, Blowey DL, Sullivan JE, Blumer J, Sherbotie JR, Song S, Rohatagi S, Heyrman R, Salazar DE. Pharmacokinetics of Olmesartan Medioximil in Pediatric Patients with Hypertension. 2012; 14 (5): 1-9.
    10. Wells T, Blumer J, Meyers KE, Neto JP, Meneses R, Litwin M, Vande Walle J, Solar-Yohay S, Shi V, Han G. Effectiveness and safety of valsartan in children aged 6 to 16 years with hypertension. J Clin Hypertens (Greenwich). 2011 May; 13(5):357-65. PMID: 21545397.
      View in: PubMed
    11. Webb NJ, Lam C, Shahinfar S, Strehlau J, Wells TG, Gleim GW, Le Bailly De Tilleghem C. Efficacy and safety of losartan in children with Alport syndrome--results from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trial. Nephrol Dial Transplant. 2011 Aug; 26(8):2521-6. PMID: 21285125.
      View in: PubMed
    12. Wells T, Webb NJ, Shahinfar S, Massaad R, Gleim G, Santoro EP, Sisk CM, Lam C. Longterm Maintenance Efficacy with Losartan in Children with Proteinuria: Results of a Randomized Controlled Trial. 2011; 22:198A.
    13. Wells TG, Portman R, Norman P, Haertter S, Davidai G. Safety, efficacy, and pharmacokinetics of telmisartan in pediatric patients with hypertension. Clin Pediatr (Phila). 2010 Oct; 49(10):938-46. PMID: 20724342.
      View in: PubMed
    14. Webb NJ, Lam C, Loeys T, Shahinfar S, Strehlau J, Wells TG, Santoro E, Manas D, Gleim GW. Randomized, double-blind, controlled study of losartan in children with proteinuria. Clin J Am Soc Nephrol. 2010 Mar; 5(3):417-24. PMID: 20089489; PMCID: PMC2827569.
    15. Wells TG, Mohammad Ilyas, Russell W. Chesney, Deborah P. Jones. Neonatal and Pediatric Pharmacology. Antihypertensive Agents. 2010; 49.
    16. Blumer J, Batisky DK, Wells T, Shi V, Solar-Yohay S, Sunkara G. The Pharmacokinetics of Valsartan in Pediatric and Adolescent Subjects with Hypertension. 2009; 49:235-241.
    17. Wells T, Blumer, Jeffrey, Batisky, Donald L, Shi, Victor, Solar-Yohay, Susan, Sunkara Gangadhar. Pharmacokinetics of Valsartan in Pediatric and Adolescent Subjects with Hypertension. J Clin Pharmacol. 2009; (49:235-241).
    18. Blumer J, Batisky DL, Wells T, Shi V, Solar-Yohay S, Sunkara G. The Pharmacokinetics of Valsartan in Pediatric and Adolescent Subjects with Hypertension. J Clin Pharmacol. 2009; 49:235-241.
    19. Franks AM, O'Brien CE, Stowe CD, Wells TG, Gardner SF. Candesartan cilexetil effectively reduces blood pressure in hypertensive children. Ann Pharmacother. 2008 Oct; 42(10):1388-95. PMID: 18664605.
      View in: PubMed
    20. Nesmith JD, Ilyas M, Jo C, Gossett J, Simpson P, Wells TG. Evidence of Glomerular Hyperfiltration in Obese Non-Diabetic Youth. 2008.
    21. Wells TG, Blumer J, Litwin M, Solar-Yohay S, Shi V. Effectiveness and Safety of Valsartan in Hypertensive Children Ages 6-16 Years. 2008.
    22. Wells TG, Blumer J, Litwin M, Solar-Yohay S, Shi V. Safety and Effectiveness of Valsartan in Hypertensive Children Ages 6-16 Years. 2008; A79-80.
    23. Batisky D, Wells TG, Delucchi A, Pinto V, Shi V, Solar-Yohay S, Sunkara G. Pharmacokinetics of valsartan in 1 to 16 year old children. 2008; A79.
    24. Hogg RJ, Delucchi A, Sakihara G, Wells TG, Tenney F, Batisky DL, Blumer JL, Vogt BA, Lo MW, Hand E, Panebianco D, Rippley R, Shaw W, Shahinfar S. A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension. Pediatr Nephrol. 2007 May; 22(5):695-701. PMID: 17216247.
      View in: PubMed
    25. Abdel-Rahman SM, Reed MD, Wells TG, Kearns GL. Considerations in the Rational Design and Conduct of Phase I/II Pediatric Clinical Trials: Avoiding the Problems and Pitfalls. Clin Pharmacol Ther. 2007; 81(4):483-94.
    26. Chien S, Wells TG, Blumer JL, Kearns GL, Bradley JS, Bocchini JA, Natarajan J, Maldonado S, Noel GJ. Levofloxacin pharmacokinetics in children. J Clin Pharmacol. 2005 Feb; 45(2):153-60. PMID: 15647407.
      View in: PubMed
    27. Wells TG, Ilyas M. Neonatal and Pediatric Pharmacology: Therapeutic Principles in Practice. Antihypertensive Agents. 2005.
    28. Wells TG. Pediatric Hypertension. Pediatric Antihypertensive Trials. 2004.
    29. Maples HD, James LP, Stowe CD, Jones DP, Hak EB, Blumer JL, Vogt B, Wilson JT, Kearns GL, Wells TG. Famotidine disposition in children and adolescents with chronic renal insufficiency. J Clin Pharmacol. 2003 Jan; 43(1):7-14. PMID: 12520622.
      View in: PubMed
    30. Wells T, Frame V, Soffer B, Shaw W, Zhang Z, Herrera P, Shahinfar S. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension. J Clin Pharmacol. 2002 Aug; 42(8):870-80. PMID: 12162469.
      View in: PubMed
    31. Stowe CD, Gardner SF, Gist CC, Schulz EG, Wells TG. 24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy. Ann Pharmacother. 2002 Jul-Aug; 36(7-8):1142-9. PMID: 12086544.
      View in: PubMed
    32. Wells TG. Antihypertensive therapy: basic pharmacokinetic and pharmacodynamic principles as applied to infants and children. Am J Hypertens. 2002 Feb; 15(2 Pt 2):34S-37S. PMID: 11866226.
      View in: PubMed
    33. Chesney R, Adamson P, Wells T, Wilson J, Walson P. Report of the antihypertensive agen guidelines subcommittee of the pediatric pharmacology research units (PPRU). Pediatrics. 2001; 107:558-61.
    34. Wells TG, Shaw W, Rippley R, Tenney F, Hogg R, Blowey D, Walson P, Blumer J, Delucchi A, Shahinfar S. The Pharmacokinetics of Enalapril in Children and Adolescents. J Clin Pharmacol. 2001; 41:1064-1074.
    35. Wells T, Stowe C. An approach to the use of antihypertensive drugs in children and adolescents. Curr Ther Res Clin Exp. 2001; 62(329-50).
    36. Sakarcan A, Tenney F, Wilson JT, Adcock KG, Wells TG, Vachharajani NN, Hadjilambris OW, Slugg P, Ford NF, Marino MR. The Pharmacokinetics of Irbesartan in Hypertensive Children and Adolescents. J Clin Pharmacol. 2001; 41:742-749.
    37. Ellis EN, Floyd-Gimon D, Berry P, Wells TG, Seibert J, Belsha C. Rish Factors for Bone Mineral Density Loss in Pediatric Renal Transplant Patients. Pediatr Transplantation. 2000; 4:146-150.
    38. Kearns GL, Abdel-Rahman SM, James LP, Blowey DL, Marshall JD, Wells TG, Jacobs RF. Single Dose Pharmacokinetics of Pleconaril (VP63843) Oral Solution in Children and Adolescents, Antimicrob Agents Chemother. Anitmicrob Agents Chemother. 1999; 43:634-638.
    39. Belsha CW, Wells TG, McNiece KL, Seib PM, Plummer JK, Berry PL. Influence of Diurnal Blood Pressure Variations on Target Organ Abnormalities in Hypertensive Adolescents. Am J Hypertension. 1998; 11:410-417.
    40. Wells TG, Neaville WA, Arnold JR, Belsha CW. Evaluation of Manual and Semi-Automated Home Blood Pressure Monitors in Children and Adolescents. Amer J Med Sci. 1998; 315:110-117.
    41. Marshall JD, Wells TG, Letzig L, Kearns GL. Pharmacokinetics and Pharmacodynamics of Bumetanide in Critically Ill Pediatric Patients. J Clin Pharmacol. 1998; 38:994-1002.
    42. Kearns GL, Abdel-Rahman SM, Jacobs RF, Wells TG, Borin MT. Cefpodoxime Pharmacokinetics in Infants and Children: Effect of Prandial State. Pediatr Infect Dis J. 1998; 17:799-804.
    43. Belsha CW, Wells TG, House ME, Rice HB, Neaville WA, Berry PL. Evaluation of the Spacelabs 90207 Ambulatory Blood Pressure Monitor in Children and Adolescents. Blood Pressure Monitoring. 1996; 1:127-133.
    44. Kearns GL, Darville T, Wells TG, Jacobs RF, Hughes GS, Borin MT. Single-Dose Pharmacokinetics of Cefpodoxime Proxetil in Infants and Children. Clin Drug Invest. 1996; 10:71-80.
    45. Kearns GL, Weber W, Harnisch L, Darville T, Blumer JL, Powell K, Wells TG, Jacobs RF. Single-Dose Pharmacokinetics of Cefpodoxime in Pediatric Patients. Clin Drug Invest. 1996; 10:71-80.
    46. Wells TG, Taylor BJ, Fasules JW, Kearns GL. Disposition and Pharmacodynamics of Bumetanide in Neonates Receiving Extracorporeal Membrane Oxygenation. J Pediatr. 1992; 121:974-980.
    47. Wells TG, Hendry IR, Kearns GL. Measurement of Bumetanide in Plasma and Urine using High-Performance Liquid Chromatography and Application to Bumetanide Disposition. J Chromatrogr. 1991; 570:235-242.
    48. Wells TG, Sinaiko AR. Antihypertensive Efficacy and Pharmacokinetics of Nitrendipine in Children. J Pediatr. 1991; 118:638-643.
    49. Ellis EN, Watts K, Wells TG, Arnold WC. Use of the Peritoneal Equilibrium Test in Pediatric Dialysis Patients. Adv Peritoneal Dial. 1991; 7:259-261.
    50. Farrar HC, Wells TG, Kearns GL. Safety and Efficacy of Continuous Infusion Pralidoxime for Treatment of Organophosphate Poisoning in Children. J Pediatr. 1990; 116:658-661.
    51. Gonzalez R, Reinberg Y, Burke B, Wells T, Vernier RL. Early Bladder Outlet Obstruction in Fetal Lambs Induces Renal Dysplasia and the Prune Belly Syndrome. J Pediatr Surg. 1990; 25:342-345.
    52. Sinaiko AR, Wells TG. Childhood Hypertension. Hypertension: Pathophysiology, Diagnosis, and Management. 1989.
    53. Wells TG, Ulstrom RA, Nevins TE. Hypoglycemia in Pediatric Renal Allograft Recipients. J Pediatr. 1988; (113):1002-1007.
    54. Jacobs RF, Steele RW, Yamauchi T. A Prospective Randomized Comparison of Cefotaxime Versus Ampicillin and Chloramphenicol for Bacterial Meningitis in Children. J Pediatr. 1985; (107):129-133.
    55. Wells TG, Kearns GL, Stillwell PC, Brown AL, Trang JM, McConnell RF, Kluza RB. Rapid Estimation of Serum Theophylline Clearance in Children with Acute Asthma. Ther Drug Monit. 1984; 6:402-406.
    56. Wells TG, Bowe Rice HL, Neaville WA, Shema SJ, Roberson PK, House M, Belsha CW. Cardiovascular Effects of Pseudoephedrine in Normatensive and Hypertensive Children. 65A.
    57. Pearson D, Robinson L, Ellis EN, Belsha C, Wells TG, Berry P. Pump-Assisted Hemofiltration in Infants. 797A.
    58. Shaw W, Hogg R, Delucchi A, Sakihara G, Wells TG, Tenney F, Batisky D, Blumer J, Vogt B, Murphy G, Lo M-W, Hand E, Panebianco D, Rippley R, Shahinfar S. Lisinoprol Pharmacokinetics in hypertensive Children and Infants. 46A.
    59. Kearns G, Jacobs R, Darville T, Wells TG, Borin M. Single-Dose Pharmacokinetics of Cefpodoxime in Infants and Children. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy.
    60. Ellis EN, Gimon D, Belsha C, Wells TG, Berry P, Seibert J. Bone Mineral Density and Puberty in Pediatric Renal Transplant Patients. 1931.
    61. Wells TG, Zhou SY, Hammet J, Slugg P, Reeves RA. Single-Dose Pharmacokinetics of an Oral Solution of Fosinopril in Children. 1029.
    62. Wells TG, House M, Belsha CW, Berry PL. Treatment of Pediatric Hypertension with Isradipine. 814A.
    63. Wells TG, Howard L, Lowery N, Parker J, Simpson P. Methodology in Pediatric Antihypertensive Trials. A220.
    64. Marshall J, Heulitt M, Kearns G, Wells TG. Continuous Infusion Versus Intermittent Intravenous Bumetanide in Children. 179.
    65. Belsha CW, Plummer JK, Wells TG, Berry PL, Ellis EN. Outcome of Hypertensice Infants Treated with Angiotensin Converting Enzyme Inhibitors. 21A.
    66. Ellis EN, Gimon D, Belsha C, Wells TG, Berry P, Seibert J. Fellow Up Bone Mineral Density in Pediatric Renal Transplant Patients. 712A.
    67. Sullivan JE, Yamashita TS, Wells TG, Blumer JL. Pharmacokinetics and Pharmacodynamics of Bumetanide in Critically Ill Children. 180.
    68. Ellis EN, Pearson D, Robinson L, Belsha C, Wells TG, Berry P. Use of Pump-Assisted Hemofiltration for Acute Renal Failure in Infants. 355A.
    69. Chien S, Wells TG, Bradley J, Kearns GL, Bocchini J, Maldonado S, Noel GJ. Pharmacokinetics of Levofloxacin Oral Suspension in Infants and Children. Preceedings of the 42nd Meeting of ICAAC.
    70. Wells TG, SinaikoAR. Antihypertensive Efficacy and Pharmacokinetics of Nitrendipine in Children. C191.
    71. Belsha CW, Wells TG, House ME, Bowe Rice HL, Neaville WA, Berry PL. Evaluation of the Spacelabs 90207 Ambulatory Blood Pressure Monitor (ABPM) in Children and Adolscents. 65A.
    72. Belsha C, Wells TG, McNiece K, Plummer J, Seib P, Roberson P, Berry P. Influence of Left Ventricular Mass on Diurnal Blodd Pressure in Hypertensive Adolescents. 1546.
    73. Sinaiko AR, Wells TG. Influence of Sympathetic Nervous System(SNS) on Renal (Na+-K+) ATPase Activity in the Dahl Rat. 43A.
    74. Petersen PO, Wells TG, Kearns GL. Evaluation of a Dosing Nomogram for Amikacin in Neonates. 65A.
    75. Wells TG, Nevins TE. Hypoglycemia in Pediatric Renal Allograft Recipients. 486A.
    76. Kearns GL, Wells TG. Pharmacokinetics of Pralidoxime(2PAM) in Children. 163.
    77. Love JC, Kearns GL, Wells TG, Baker L. Effect of ECMO on Amphotericin Disposition In Vitro. Proceedings and Abstracts of the 1993 Midwinter ELSO Meeting.
    78. Rippley R, Shahinfar S, Hogg R, Sakarcan A, Delucchi A, Blowey D, Walson P, Vogt B, Murphy G, Lo M, Hand E, Shaw W, Wells TG. Pharmacokinetics of Enalapril in Hypertensive Children and Infants. 126A.
    79. James LP, Marshall J, Heulitt M, Wells TG, Kearns G. Pharmacokinetics (PK) and Pharmacodynamics (PD) of Famotidine in Children. 179.
    80. Capparelli E, LeCreta F, Blumer J, Bradley J, Wells TG, Kearns G, Swingle M, Duncan G, Grasela D. Single Dose Safety and Pharmacokinetics (PK) of Oral Gatifloxacin in Pediatric Patients. Proceedings of the 40th Meeting of ICAAC.
    81. Soffer BA, Shahinfar S, Shaw W, Zhang Z, Herrera P, Frame V, Wells TG. Effects of the ACE Inhibitor, Enalapril, in Children Age 6-16 Years with Hypertension. 452A.
    82. Hine JR, Wells TG, Roberson P, Shema SJ. Folate Status and Homocystine Levels of Children at High and Low Risk of Cardiovascular Disease. 533.
    83. Wells TG, House M, Belsha CW, Berry PL. Isradipine Treatment of Hypertension in Children. 59A.
    84. Wells TG, House M, Arnold JR, Neaville WA, Ellis EN, Belsha CB, Berry PL. Evaluation of Home Blood Pressure Monitors in Pediatric Patients. 730A.
    85. Wells TG, House M, Arnold JR, Neacille WA, Ellis EN, Belsha CB, Berry PL. Evaluation of Manual and Semi-Automated Home Blood Pressure Monitors in Pediatric Patients. 376A.
    86. Kelly NR, Ellis EN, Wells TG. Use of Urinary Protein/Creatinine Ratios in Childhood. 359A.
    87. Schexnayder S, Farrar H, James LP, Wells TG, Kearns G. Continuous Infusion Pralioxime in the Treatment of Organophosphate Ingestion: Pharmacokinetics in Children. 53A.
    88. Chien S, Abels R, Blumer J, Goldstein H, Kearns G, Maldonado S, Noel G, Wells TG, Spielberg S. Single-Dose Pharmacokinetics and Tolerability of Intracenous Levofloxacin in Pediatric Patients. Proceedings of the 41st Meeting of ICAAC.
    89. Kelly NR, Ellis EN, Wells TG. Urinary Protein/Creatinine Ratios in Children. 797A.
    90. Belsha CW, Wells TG, Neaville WA, Bowe Rice HL, House ME, Berry PL. Evaluation of the Dinamap 8100 Oscillometric Blood Pressure Monitor in Children and Adolescents. 79A.
    91. Shaw W, Hogg R, Delucchi A, Sakihara G, Wells TG, Tenney F, Batisky D, Blumer J, Vogt B, Murphy G, Lo M-W, Hand E, Panebianco D, Rippley R, Shahinfar S. Multicenter Study of Lisinopril Pharmacokinetics in Hypertensive Children and Infants. 431A.
    92. Sakarcan A, Tenney FW, Wilson JT, Stewart JJ, Adcock KG, Wells TG, Vachharajani NN, Hadjilambris O, Slugg P, Ford NF, Marino MR. Irbesartan Pharmacokinetics in the Pediatric Population. 354A.
    93. Kearns GL, Wells TG, Blowey DL, Jackson MA, Burry VF. Pharmacokinetics of VP63843 in Children. 193.
    94. Maples H, James LP, Stowe C, Chesney R, Christensen M, Blumer J, Wilson J, Wells TG, Kearns G. Pharmacokinetics of Famotidine in Children and Adolescents with Chronic Renal Failure. P4.
    95. Trang JM, Kearns GL, Jacobs RF, Brown AL, Wells TG, Underwood FL, Kluza RB. Cefotaxime and Desacetylcefotaxime Pharmacokinetics in Children with Meningitis. 882A.
    96. Shaw W, Hogg R, Koch V, Wells TG, Frishberg Y, Jones D, Delucchi A, Hernandez O, Tenney F, Romero B, Murphy G, Lo Man-Wai, Panebianco D, Shahinfar S. Losartan and E-3174 Pharmacokinetics in Hypertensice Children and Infants. 149A.
    97. Wells TG, Kearns GL, Kluza RB, Stillwell PC, Brown AL, McConnell RF, Fiser DH. Evaluation of Pre-Steady State Methods for Determining Therophylline Plasma Clearance in Children. 893A.
    98. Belsha CW, Wells TG, Plummer JK, Roberson PK, Berry PL. Blood Pressure Patterns in Normatensive and Hypertensice Children and Adolescents. 67A.
    99. Levitt B, Chapelsky M, Boyle G, Wells TG, Jones S, Jorkasky DK. Safety and Pharmacokinetics of Nabumetone and 6-MNA in Juvenile Rheumatiod Arthritis Patients Following Repeated Oral Doses of Nabumetone Chewable Tablets.
    100. Kearns GL, Kletzel M, Wells TG, Thompson HC. Pharmacokinetics of High Dose Thiotepa in Children. 161.
    101. Wells TG, Lange BM, Plummer JK, Belsha CW. Elevated Blood Pressure in Children with Tourette's Syndrome. 68A.
    102. Stillwell PC, Wells TG, Kearns GL, Brown AL, McConnell RF, Kluza RB. Rapid assessment of theophylline plasma clearance and dose requirement in children with acute asthma. 223A.
    103. Soffer BA, Shahinfar S, Shaw W, Zhang Z, Herrera P, Frame V, Wells TG. Effects of the ACE Inhibitor, Enalapril, in Children Age 6-16 Years with Hypertension. 126A.
    104. Belsha CW, Wells TG, Berry PL, Ellis EN. A Validation Study of an Ambulatory Blood Pressure Monitoring Device for Use in Children and Adolescents. 844A.
    105. Wells TG, Shema SJ, Roberson PK, House ME, Belsha CW. Cardiovascular Effects of Pseudoephedrine in Normotensive and Hypertensive Children. 81A.
    106. Belsha CW, Wells TG, Ellis EN, Berry PL. Validation Study of an Ambulatory Blood Pressure Monitoring Device in Children and Adolescents. 352A.
    107. Wells TG, Ellis EN, Casteel HB, Hendry IR, Kearns GL. Pharmacokinetics of Single Dose Midazolam in Children. 160.
    108. Kearns GL, Casteel HB, Taylor BJ, Wells TG, Myers CM, Reed MD. Pharmacokinetics of Metoclopramide in Neonates with Gastroesophageal Reflux. 61A.
    109. Belsha CW, Wells TG, Plummer J, Berry PL. Diurnal Blood Pressure Patterns in Normotensive and Hypertensive Children. 637.
    110. Wells TG, Heulitt M, Fasules JW, Taylor BJ, Kearns GL. Disposition of Ranitidine in Neonates Treated with Extracorporeal Membrane Oxygenation (ECMO). Preceedings of the Fourth Annual Meeting of the Extracorporeal Life Support Organization.
    111. Wells TG, Ellis EN, Casteel HB, Fiedorek SC, Kearns GL. Single dose Midazolam for Sedation During Invasive Procedures in Children. 969A.
    112. Shahinfar S, Rippley R, Hogg R, Sakarcan A, Delucchi A, Blowey D, Walson P, Vogt B, Murphy G, Lo M, Hand E, Shaw W, Wells TG. Multicenter Study of Enalapril Pharmacokinetics in Hypertensive Children and Infants. 473A.
    113. Seibert JJ, Kinder D, Cox K, Kidzy B, Flick E, Lensing S, Faucett D, Wells TG, Ellis E, Belsha C, Pihoker K, Jones J, Curtis M, Leithiser R, Klein S, Vanderzalm D. Pediatric Bone Densitmoetry Measured by Dual XRay Absorption: Normal Values and Disease Processes.
    114. James LP, Marshall JD, Heulitt MJ, Wells TG, Kearns GL. Pharmacokinetics and Pharmacodynamics of Famotidine in Infants and Children. 59A.
    115. Wells TG, Zhang Z, Soffer B, Shaw W, Herrera P, Shahinfar S. Antihypertensive Trial Design in Children: Blood Pressure Variability Among the Hypertensive Children Enrolled in the Enalapril Pediatric Study. 109A.
    116. Wells TG, Blasier RD, Kearns GL. Pharmacokinetics of Naproxen Tablets and Suspension in Children. 758.
    117. Wells TG, Taylor BJ, Fasules JW, Kearns GL. Bumetanide Disposition in Neonates on Extracorporeal Membrane Oxygenation (ECMO). 67A.
    118. Schexnayder S, Kearns G, Wells TG. Pharmacokinetics of Continuous Infusion Pralidoxime in Infants and Children with Organophosphate Poisoning. 832A.
    Wells's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Physical Neighbors Expand Description
    _